Artal International S.C.A. 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 5:08 pm Sale |
2023-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Artal International S.C.A. | 0 0.000% |
-15,066,043 (Position Closed) |
Filing |
| 2023-02-10 7:21 pm Unchanged |
2022-12-31 | 13G | Ambrx Biopharma Inc. AMAM |
Artal International S.C.A. | 15,066,043 5.600% |
0 (Unchanged) |
Filing |
| 2021-07-12 4:56 pm Purchase |
2021-06-22 | 13G | Ambrx Biopharma Inc. AMAM |
Artal International S.C.A. | 15,066,043 5.700% |
15,066,043 (New Position) |
Filing |